Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Liabilities and Shareholders Equity (2019 - 2025)

Historic Liabilities and Shareholders Equity for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to $1.3 billion.

  • Cresco Labs' Liabilities and Shareholders Equity fell 741.86% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 billion, marking a year-over-year decrease of 205.07%. This contributed to the annual value of $1.4 billion for FY2024, which is 22.91% down from last year.
  • Per Cresco Labs' latest filing, its Liabilities and Shareholders Equity stood at $1.3 billion for Q3 2025, which was down 741.86% from $1.3 billion recorded in Q2 2025.
  • Cresco Labs' Liabilities and Shareholders Equity's 5-year high stood at $1.8 billion during Q1 2022, with a 5-year trough of $1.3 billion in Q3 2025.
  • In the last 5 years, Cresco Labs' Liabilities and Shareholders Equity had a median value of $1.4 billion in 2021 and averaged $1.5 billion.
  • As far as peak fluctuations go, Cresco Labs' Liabilities and Shareholders Equity surged by 4444.82% in 2021, and later plummeted by 2033.48% in 2023.
  • Quarter analysis of 5 years shows Cresco Labs' Liabilities and Shareholders Equity stood at $1.8 billion in 2021, then dropped by 11.05% to $1.6 billion in 2022, then decreased by 14.22% to $1.4 billion in 2023, then decreased by 0.23% to $1.4 billion in 2024, then decreased by 5.53% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.4 billion during Q1 2025.